UBS Group’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,567
Closed -$39.3K 8968
2024
Q1
$39.3K Buy
+4,567
New +$39.3K ﹤0.01% 5455
2023
Q2
Sell
-301
Closed -$11.4K 8692
2023
Q1
$11.4K Buy
301
+264
+714% +$9.97K ﹤0.01% 6417
2022
Q4
$1.11K Sell
37
-7
-16% -$209 ﹤0.01% 8754
2022
Q3
$1K Buy
+44
New +$1K ﹤0.01% 9003
2022
Q2
Sell
-241
Closed -$13K 9949
2022
Q1
$13K Buy
+241
New +$13K ﹤0.01% 7041
2021
Q4
Sell
-4
Closed 9542
2021
Q3
$0 Sell
4
-106
-96% ﹤0.01% 8930
2021
Q2
$14K Sell
110
-32
-23% -$4.07K ﹤0.01% 6628
2021
Q1
$23K Buy
+142
New +$23K ﹤0.01% 6235
2020
Q4
Sell
-231
Closed -$23K 7718
2020
Q3
$23K Sell
231
-401
-63% -$39.9K ﹤0.01% 5356
2020
Q2
$24K Buy
632
+569
+903% +$21.6K ﹤0.01% 5599
2020
Q1
$2K Sell
63
-124
-66% -$3.94K ﹤0.01% 6736
2019
Q4
$9K Buy
187
+153
+450% +$7.36K ﹤0.01% 6277
2019
Q3
$3K Sell
34
-7
-17% -$618 ﹤0.01% 6701
2019
Q2
$6K Sell
41
-4
-9% -$585 ﹤0.01% 6458
2019
Q1
$12K Hold
45
﹤0.01% 5868
2018
Q4
$6K Sell
45
-29
-39% -$3.87K ﹤0.01% 6570
2018
Q3
$31K Buy
74
+3
+4% +$1.26K ﹤0.01% 5613
2018
Q2
$38K Buy
71
+45
+173% +$24.1K ﹤0.01% 5312
2018
Q1
$12K Sell
26
-21
-45% -$9.69K ﹤0.01% 5886
2017
Q4
$31K Buy
47
+10
+27% +$6.6K ﹤0.01% 5249
2017
Q3
$23K Sell
37
-5
-12% -$3.11K ﹤0.01% 5458
2017
Q2
$20K Buy
42
+19
+83% +$9.05K ﹤0.01% 5371
2017
Q1
$17K Hold
23
﹤0.01% 5355
2016
Q4
$23K Sell
23
-2
-8% -$2K ﹤0.01% 5496
2016
Q3
$33K Buy
25
+3
+14% +$3.96K ﹤0.01% 4978
2016
Q2
$19K Buy
22
+7
+47% +$6.05K ﹤0.01% 5477
2016
Q1
$21K Hold
15
﹤0.01% 5342
2015
Q4
$28K Buy
15
+12
+400% +$22.4K ﹤0.01% 5264
2015
Q3
$5K Sell
3
-29
-91% -$48.3K ﹤0.01% 6299
2015
Q2
$71K Buy
32
+19
+146% +$42.2K ﹤0.01% 4530
2015
Q1
$36K Buy
+13
New +$36K ﹤0.01% 4910